Greece Approves Drug Colchicine in the Fight Against Covid - Greek Reporter

On Sunday, Greece approved colchicine, an inexpensive medicine for heart diseases, to be included in the protocol of oral treatments for patients with Covid-19.

The study showed that the administration of colchicine to Covid-19 patients “reduced mortality by 44%, hospitalization by 25% and the need for intubation by 50%,” professor of cardiology Spyros Deftereos, who coordinated the study in Greece told Athens-Macedonia News Agency (AMNA).

The study of the treatment of Covid-19 by colchicine was conducted by a team of researchers from the Montreal Heart Institute.

“Our study showed the effectiveness of treatment using colchicine to prevent the phenomenon of the major inflammatory storm and reduce complications related to COVID-19,” he said.